Targeting Lung and Colon Cancers and Glioblastoma Using New Photon-Counting Technique, University of Akron Study

Published: Feb 28, 2013

For scientists to improve cancer treatments with targeted therapeutic drugs, they need to be able to see proteins prevalent in the cancer cells. This has been impossible, until now. Thanks to a new microscopy technique, University of Akron researcher Dr. Adam Smith, assistant professor of chemistry, has observed how clusters of epidermal growth factor receptor (EGFR) - a protein abundant in lung and colon cancers, glioblastoma and others - malfunctions in cancer cells.

Back to news